Literature DB >> 17956290

Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase.

J S Oak1, M P Matheu, I Parker, M D Cahalan, D A Fruman.   

Abstract

The PI3K (phosphoinositide 3-kinase) family of lipid kinases regulate cell motility in diverse organisms and cell types. In mammals, the main PI3K enzyme activated by chemokine receptor signalling is the class IB isoform, p110gamma. Studies of p110gamma-knockout mice have shown an essential function for this isoform in chemotaxis of neutrophils and macrophages both in vitro and in vivo. However, the roles of p110gamma and other PI3K enzymes and regulatory subunits in lymphocyte motility have been more difficult to discern. Recent studies of adoptively transferred, fluorescently labelled lymphocytes have revealed complex and unexpected functions for PI3K in lymphocyte migration in vivo. In this review we highlight cell-type-specific roles for PI3K catalytic and regulatory subunits in the homing and basal motility of lymphocytes in the intact lymph node.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956290      PMCID: PMC2953540          DOI: 10.1042/BST0351109

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  44 in total

1.  Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesis.

Authors:  Agnieszka N Stachowiak; Yana Wang; Yen-Chen Huang; Darrell J Irvine
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

2.  Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes.

Authors:  Marc Bajénoff; Jackson G Egen; Lily Y Koo; Jean Pierre Laugier; Frédéric Brau; Nicolas Glaichenhaus; Ronald N Germain
Journal:  Immunity       Date:  2006-11-16       Impact factor: 31.745

3.  T-lymphocyte navigation and migration: beyond the PI3K paradigm.

Authors:  L Smith; A Webb; S G Ward
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

4.  The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity.

Authors:  D A Fruman
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

Review 5.  PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?

Authors:  Thomas Rückle; Matthias K Schwarz; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2006-10-13       Impact factor: 84.694

6.  Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.

Authors:  David J J de Gorter; Esther A Beuling; Rogier Kersseboom; Sabine Middendorp; Janine M van Gils; Rudolf W Hendriks; Steven T Pals; Marcel Spaargaren
Journal:  Immunity       Date:  2007-01       Impact factor: 31.745

7.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

8.  CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo.

Authors:  Tim Worbs; Thorsten R Mempel; Jasmin Bölter; Ulrich H von Andrian; Reinhold Förster
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

Review 9.  Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K.

Authors:  Klaus Okkenhaug; Khaled Ali; Bart Vanhaesebroeck
Journal:  Trends Immunol       Date:  2007-01-05       Impact factor: 16.687

10.  Drugging the PI3 kinome.

Authors:  Paul Workman; Paul A Clarke; Sandrine Guillard; Florence I Raynaud
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

View more
  4 in total

1.  Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance.

Authors:  Naoki Kobayashi; Kohjiro Ueki; Yukiko Okazaki; Aya Iwane; Naoto Kubota; Mitsuru Ohsugi; Motoharu Awazawa; Masatoshi Kobayashi; Takayoshi Sasako; Kazuma Kaneko; Miho Suzuki; Yoshitaka Nishikawa; Kazuo Hara; Kotaro Yoshimura; Isao Koshima; Susumu Goyama; Koji Murakami; Junko Sasaki; Ryozo Nagai; Mineo Kurokawa; Takehiko Sasaki; Takashi Kadowaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 2.  New insights into the regulation and function of serine/threonine kinases in T lymphocytes.

Authors:  Sharon A Matthews; Doreen A Cantrell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 3.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

4.  Comparative proteomic analysis implicates eEF2 as a novel target of PI3Kγ in the MDA-MB-231 metastatic breast cancer cell line.

Authors:  Meizhi Niu; Manuela Klingler-Hoffmann; Julie A Brazzatti; Briony Forbes; Chareeporn Akekawatchai; Peter Hoffmann; Shaun R McColl
Journal:  Proteome Sci       Date:  2013-01-15       Impact factor: 2.480

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.